Print Page

ADRs that result in revision of product information or suspension of marketing authorisation

 
The United Kingdom: Abrysvo▼(Pfizer RSV vaccine) and Arexvy▼(GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults
 
 
 
Attachment:
  1. The United Kingdom: Abrysvo▼(Pfizer RSV vaccine) and Arexvy▼(GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults  
Related Information:
Australia: Updated warnings for Respiratory Syncytial Virus (RSV) vaccines Arexv... Posted 2025-05-19
FDA requires Guillain-Barré Syndrome (GBS) warning in the prescribing informatio... Posted 2025-01-08
The United States: FDA requires Guillain-Barré Syndrome (GBS) warning in the pre... Posted 2025-01-08
 
back